The company expired its plan on April 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.93 CNY | +0.07% | -0.86% | -1.39% |
04-29 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.39% | 2.47B | |
+37.20% | 723B | |
+32.22% | 598B | |
-2.30% | 364B | |
+20.07% | 331B | |
+3.07% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+8.65% | 169B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on May 6, 2022, has expired.